Brancous Amends Proxy Fight: Sues Braemar Over Nominee Validity Ahead of Dec 21 Vote
BHR is trading near its 52-week low of $1.18 (12% above the low).
Summary
Brancous amended its preliminary proxy for the December 21 annual meeting, adding a Maryland lawsuit challenging Braemar's rejection of its five nominees and disclosing Braemar's eight-person counter-slate. At stake is who oversees the $480 million Ashford termination payment and the remaining hotel sales.
Key Events · Corporate Governance and Compliance · BHR
-
Brancous Sues Over Nominee Validity
On October 21, 2026, Brancous filed a verified complaint in the Circuit Court for Baltimore City, Maryland (No. C-24-CV-26-007064), seeking a declaratory judgment that its five nominees were properly nominated and an injunction barring the Company from refusing to recognize them or count votes for them.
-
Five Nominees Would Hold Board Majority
Brancous beneficially owns 650,010 shares, about 0.9% of the 68,679,318 shares outstanding as of August 4, 2026. Electing all five nominees to the eight-seat board would give them a majority.
-
Company Counters With Eight Nominees
Braemar announced on October 26, 2026 that it intends to nominate Craig Barbarosh, Kevin Covey, Stephen Haggerty, Daniel Hirsch, Kevin Luebbers, Gail Steinel, Richard Stockton and Stephen Theriot, while maintaining that Brancous's nominations are invalid.
-
Ashford Fee Looms Over the Vote
Under the amended letter agreement with Ashford Inc., Braemar agreed to pay a discounted $480 million plus accrued fees from net sale proceeds before any other payments or distributions; Brancous wants an independent review of how that fee was calculated.
Analysis · BHR · Real Estate & Construction
Brancous, a 0.9% holder, is pressing a five-seat proxy contest against a company that just settled with its largest shareholder, Al Shams, for $25 million plus $15 million in expenses. What makes this amendment matter is that the outcome now hinges on the courts: Braemar says the nominations are invalid (partly because notice came by e-mail), and Brancous sued in Maryland on October 21 seeking a declaration and an injunction. Should Brancous prevail, its five nominees would hold a majority of the eight-member board and could reopen the $480 million Ashford termination fee — a payment larger than the entire market value of the common stock. If Braemar wins, votes for those nominees can be disregarded. The December 21 meeting is the decision point.
How filings like this one have moved
In the 30 days to Oct 28, 2026, 30.7% of the 1698 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BHR was trading at $1.32 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $90.7M. The 52-week trading range was $1.18 to $3.19. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.